| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |